People channel feed – Endpoints News

People channel feed

ObsEva makes cuts to leadership team, board of directors in another attempt to stay afloat

3 years ago

February freeze hits biotech as companies cut staff, thin pipelines and merge to survive

3 years ago

Third Rock shrinks another biotech as Cedilla restructures, CEO and CBO depart

3 years ago

EQRx to trim more than 40 staffers in restructuring maneuver

3 years ago

Graphite Bio gives up on lead sickle cell program, halves staff in wake of safety scare

3 years ago

Cerevel blames Covid for delayed neuroscience studies, says president is leaving

3 years ago

Rubius fails to find alternative as board approves dissolution

3 years ago

Vivek Ramaswamy launches bid for US presidency, resigns from Roivant board

3 years ago

Cancer biotech ends trial, searches for sale or other route

3 years ago

Updated: Leena Gandhi leaves Dana-Farber for checkpoint inhibitor biotech

3 years ago

Updated: Resilience to cut most staff, suspend operations at Massachusetts manufacturing plant

3 years ago

FDA's No. 2 oncology official departs for biotech startup

3 years ago

Third Rock-backed autoimmune biotech turns off the lights

3 years ago

Kite CEO Christi Shaw to depart Gilead CAR-T unit

3 years ago

Biogen chairman Papadopoulos, who saw company through highs and lows, to retire

3 years ago

CAR-T biotech reduces staff as it hunts for capital to enter clinic next year

3 years ago

Talaris discontinues two trials, cuts staff and starts ‘strategic alternatives’ search

3 years ago

Spain's Grifols to dismiss more than 2,000 US employees in $427M cost savings bid

3 years ago

Brent Saunders to lead Bausch + Lomb in return to CEO slot

3 years ago

Harvard professor takes on the mantle of Gavi CEO

3 years ago

John Reed lands in the top R&D post at J&J in his latest Big Pharma debut

3 years ago

Vivek Ramaswamy planning a run for US president — report

3 years ago

Sanofi’s R&D chief John Reed makes surprise exit

3 years ago

Aristea shutters, ending hopes of a Pfizer buyout

3 years ago

First page Previous page 31 32 333435 36 37 Next page Last page